Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Sivers IMA launches new 60 GHz RFIC chip for WiGig

Sivers IMA today proudly announce the upcoming launch of a new beamforming transceiver RFIC at the Mobile World Congress in Barcelona February 27thto March 2nd. The TRX-BF01 is a WiGig/802.11ad compliant 16+16 beam forming transceiver. It is a carrier grade, high speed WiGig RFIC targeting data and telecommunication infrastructure applications for the networks solutions of today and tomorrow. TRX-BF01 can be used in high speed fixed wireless access (FWA), meshed networking and backhaul as well as fronthaul solutions. It is currently supporting the 60 GHz V-band.The continued 10x growth in

Noreco announces fourth quarter 2016 results

Oslo, 15 February 2017: Norwegian Energy Company ASA (“Noreco”) and the subsidiary Noreco Norway AS (“Noreco Norway”) today announce results for the fourth quarter of 2016. During the quarter the Maritime and Commercial High Court in Copenhagen announced its ruling in favour of the claimants (Noreco and its partners; Awilhelmsen Special Opportunities AS and QVT Financial LP) a total amount of approximately USD 470 million, including interest. Of the total amount, Noreco is entitled to approximately USD 270 million. There will be a company update at Arctic Securities in Oslo today at

Aker ASA: Invitation to presentation of fourth-quarter 2016 results

Aker ASA will publish its fourth-quarter and preliminary annual results for 2016 on the Oslo Stock Exchange on Tuesday 28 February 2017, at 07:00 CET. The results presentation will be held at Aker's headquarters at Fornebuporten, Oksenøyveien 10, at 09:00 CET the same morning.We invite investors, analysts and media to Aker's results presentation with President & CEO Øyvind Eriksen and CFO Frank O. Reite. Pre-registration is not required. Date: Tuesday 28 February 2017Time: 09:00 a.m. CETFormat: Live webcastLanguage: English The webcast can be followed on Aker's website www.

Double Bond Pharmaceutical expands the cooperation with Alexandrov Cancer Centre to identify biomarkers for Temodex

As previously described, DBP has recently started an extensive partnership agreement with N. N. Alexandrov National Centre of Belarus on Temodex. Now the cooperation is deepened further and includes the identification of potential biomarkers for Temodex. "Biomarkers are absolutely central in the development of modern drugs, especially as so-called personalized medicine becomes increasingly vital in the pharmaceutical world. We see a great potential and opportunities in effective development of biomarkers, - says Igor Lokot, CEO of DBP. - This ensures further the therapeutic value of

Badger Explorer ASA - approved prospectus and launch of subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATESReference is made to previous announcements from Badger Explorer ASA ("BXPL" or the "Company"). The Financial Supervisory Authority of Norway has approved a prospectus prepared by Company covering the following: The prospectus comprise (i) listing of 360,000,000 new shares (the “Private Placement I Shares") issued in a private placement conducted on 6th December 2016 (the "Private Placement I"), (ii) listing of 600,000,000 new shares (the "Private

Attendo’s year-end report and report for the fourth quarter 2016: Attendo increases new beds and reduces queues to nursing homes

Attendo showed continued stable development in the fourth quarter of 2016. Net sales for 2016 increased in line with the company’s long-term financial goal. Operating profit (EBITA) increased by 7 percent to SEK 1,002m (933), representing an operating margin of 9.8 percent (9.5). The Board proposes a dividend of SEK 1.22 (0.54) per share.Comments by Henrik Borelius, CEO “The fourth quarter of 2016 showed continued stable development.Growth was good for own nursing homes. Attendo continued to increase the number of beds under construction, which creates a good platform for growth in

FRED. OLSEN ENERGY ASA (FOE) REPORTS AN OPERATING PROFIT BEFORE DEPRECIATION (EBITDA) OF 97 MILLION FOR THE 4TH QUARTER 2016

HIGHLIGHTS FOR THE QUARTER  · Revenues were 157 million · EBITDA were 97 million · Impairment of 11 million · Operating profit (EBIT) was 22 million · Profit before tax was 19 million · Earnings per share were 0.15 · Covenant waiver request approved by the banks Post quarter event · Contract extension for Bideford Dolphin · Contract extension for Blackford Dolphin · Waiver request for the bond loan FOE05 approved by the bondholders

Finnair Group financial statement release 1 January–31 December 2016

Finnair Plc        Financial Statement Release      15 February 2017 at 9:00 am Comparable full-year operating result more than doubled year on year; positive in Q4 October–December 2016  ·  Revenue increased by 0.4% year-on-year to 569.9 million euros (567.7)*. Excluding the sold travel agencies, revenue growth was 1.2% ·  Available seat kilometres (ASK) grew by 3.5%. ·  Comparable operating result was 1.6 million euros (0.8). ·  Operating result was 18.2 million euros (85.0). The items affecting comparability were mainly related to foreign exchange gains. ·

Sweco to continue feasibility study of Helsinki-Tallinn tunnel project

Sweco is participating in the feasibility study investigating various technical solutions for the potential Helsinki-Tallinn tunnel. The study is being conducted as a joint venture between Sweco, Amberg Engineering and WSP.The Helsinki-Tallinn tunnel project is advancing to the next phase: a feasibility study focused on preparing an implementation plan to support the project’s decision-making process. This study is a continuation of the pre-feasibility study conducted by Sweco in 2015, which resolved various aspects of project execution, traffic structure and potential socioeconomic impact.

Read original

Sales development in January 2017

The H&M group’s sales including VAT increased by 8 percent in local currencies in January 2017 compared to the same month last year. Sales in January were negatively affected by approximately 2 percentage points. The total number of stores amounted to 4,380 on 31 January 2017 compared to 3,958 on 31 January 2016. Percentage sales development for the month of February and the total sales in SEK for the first quarter (December-February) will be published in a separate press release at 08.00 (CET) on 15 March 2017. The Three-Month Report, covering the period 1 December 2016 – 28 February

Tobii AB Year-End Report 2016

Tobii AB today reported its results for the fourth quarter and full year 2016. Tobii exceeded SEK 1 billion in annual sales and strengthened its cash position for increased investments in VR and smartphones. Comment by Tobii’s CEO Henrik Eskilsson: “2016 was another exciting and eventful year for Tobii. Tobii Tech passed key milestones in computer gaming, which also contributed to a significant rise in sales for the business unit for the fourth quarter. Together with Huawei, we also took our first step into the smartphone market. The rights issue that we recently carried out provides

Immunovia Financial Statement 2016

2016 in Summary • Prospective validation study of the hereditary risk group for pancreatic cancer started as planned at the end of 2016. • IMMray™ PanCan–d validated in an American patient cohort. 96% accuracy confirmed for early detection of pancreatic cancer. • Collaboration with the US National Center Institute to focus on early onset diabetes patients aged over 50. • Immunovia Scientific Advisory Board in pancreatic cancer was formed. • Immunovia Board strengthened with internationally experienced commercial leaders. • World Pancreatic Cancer Coalition was formed and

Skanska builds light rail in Lund, Sweden, for about SEK 710M

Skanska has signed a contract with the municipality of Lund to build a new tramway between Lund Central Station and the European Spallation Source (ESS), northeast of downtown. The contract is worth about SEK 710M, which will be included in the Nordic order bookings for the first quarter of 2017.The project includes 5.5 kilometers of double track and includes nine stops, a new bridge, traffic devices and installation of track, electrical, signal and telecom in the urban environment. Construction work will begin March 1 and the tramway will be ready for test runs by year end 2018.

Magnolia Bostad signs agreement to acquire three leaseholds in Bredäng

Magnolia Bostad signs an agreement to acquire the leaseholds for the properties Vita Liljan 3, Vita Liljan 4 and Utile Dulci 2 in Bredäng, Stockholm. The properties comprise a total of approximately 19,000 sqm of land and Magnolia Bostad will continue work to develop the local plan with the goal of building approximately 700 to 800 homes on the properties.The acquisition is made through three company transfers and the purchase price will be determined when a revised local plan allowing for residential construction has been accomplished. The sellers are companies mainly controlled by

THQ Nordic AB (publ) publishes Year-End Report 2016

THQ NORDIC CONTINUES TO DELIVER STRONG GROWTH We are continuing to deliver strong sales and profitability growth by executing on our core business model, which explores our well-diversified portfolio of franchises. The main driver in the quarter was continued successful promotions of our broad catalogue of IPs, on digital channels as Steam, PlayStation Network and Xbox Live. THQ Nordic had a successful IPO on Nasdaq First North Stockholm, attracting high demand from Swedish and international institutions, as well as retail investors. The available offering was 19 times oversubscribed.

Hansa Medical Year-End Report 2016

Year-End Report 2016 – Business highlightsOctober-December in brief · Swedish Phase II study successfully completed with lead candidate IdeS in sensitized kidney transplantation patients · Application for EU Orphan Drug Designation for IdeS received positive opinion from EMA and the designation was formally granted by the European Commission in January 2017 · First patient treated with IdeS in US and EU multicenter Highdes study in highly sensitized kidney transplantation patients · Phase II study in asymptomatic patients with Thrombotic Thrombocytopenic Purpura (TTP) was

Stora Enso shares converted

STORA ENSO OYJ STOCK EXCHANGE RELEASE 15 February 2017 at 9.00 EETDuring the 1–31 January 2017 conversion period there was one conversion and a total of 20 A shares were converted into R shares. The shares were recorded in the Finnish trade register today, 15 February 2017, and trading in the new R shares will start on 16 February 2017.Breakdown of shares after conversion: A shares 176 507 070R shares 612 112 917Total 788 619 987 Each A share and each ten R shares carry one vote. The total amount of votes after the conversion is at least 237 718 362.For further

World's first 5G federated network slicing grants global reach

· Deutsche Telekom, Ericsson and SK Telecom successfully demonstrate optimized end-user experiences with 5G roaming · Federated network slicing for 5G roaming extends customers' desired functionalities and service parameters into visited networks · Best of both networks for global customers when abroad Deutsche Telekom (DT), Ericsson (NASDAQ: ERIC) and SK Telecom have jointly built and demonstrated the world's first intercontinental 5G trial network. DT and SK Telecom network slices are now available in the other operator's footprint - and Germany and Korea are connected. A proof-

LeoVegas Q4: Record year with strong growth and profitability

"With a record year characterised by strong organic growth, innovation and high profitability in the fourth quarter, LeoVegas has taken yet another solid step toward our financial targets" - Gustaf Hagman, Group CEO and co-founder Fourth quarter: 1 October-31 December 2016[1] · Revenue increased by 58% to EUR 41.2 m (26.0). Growth was entirely organic. · EBITDA amounted to EUR 10.0 m (0.4), corresponding to an EBITDA margin of 24.2% (1.5%). · Operating profit (EBIT) was EUR 9.5 m (0.2). · Earnings per share were EUR 0.10 (0.00) before and after dilution. · Cash

Apartment sales begin at SRV’s first REDI tower

SRV GROUP PLC     PRESS RELEASE     15 FEBRUARY 2017, AT 9.00Apartment sales begin at SRV’s first REDI tower Sales of apartments in Majakka, the first residential tower building at REDI, Finland’s largest urban construction project, being implemented by SRV in Kalasatama, Helsinki, begin on 15 February 2017. There has been great interest in the apartments. When pre-marketing was launched in January 2016, more than half of Majakka’s 282 apartments were reserved on the first day. Currently, around 90 per cent of Majakka’s apartments have been reserved.  Majakka, which will rise to a

Terex has announced the completion of the sale of 7,450,000 Konecranes shares, Konecranes to convert sold shares into Class A shares

On February 14, 2017, Terex Corporation ("Terex") published a press release announcing that it had commenced an accelerated book-building process of up to 7,450,000 Konecranes Plc ("Konecranes" or the "Company") shares (the "Share Sale"). Today, Konecranes has received confirmation published by Terex regarding the completion of the sale of all shares offered in the Share Sale at a price of EUR 34.50 per share, representing a 3.25 percent discount to the closing price of Konecranes Class A shares on Nasdaq Helsinki on February 14, 2017. The Share Sale was multiple times oversubscribed at the

There are no items matching the current filter
There are no more items matching the current filter
Back to top